Marketing

Student Profile: Grace Guertin ’19

Posted on April 30, 2019May 10, 2019 by Claire Hall

Grace Guertin '19 (Nathan Oldham / UConn School of Business) — Grace Guertin ’19 (Nathan Oldham / UConn School of Business)

Full name: Grace GuertinContinue Reading

Connecticut Turns Up Pressure on OxyContin Maker Purdue Pharma

Posted on April 23, 2019May 7, 2019 by Melissa Ferrigno

CT Post – Connecticut’s expanded lawsuit against Purdue Pharma and its owners positions the state to more aggressively pursue its claims, but does not assure a full redress of its allegations of deceptive marketing and fraudulent finances against the much-maligned OxyContin maker.

British Drug Maker Indivior Indicted On Fraud And Conspiracy Charges In The U.S.

Posted on April 11, 2019 by Scott Slater III

NPR – Share prices for the British drugmaker Indivior plunged today on the London Stock Exchange. The drop came on news that the U.S. Justice Department indicted the company on fraud and conspiracy charges.

Do Firms Use Brands to Circumvent Regulatory Requirements?

Posted on March 21, 2019April 12, 2019 by Claire Hall

Young Business Children Make Faces Holding Lots of Money — (istockphoto.com)

Have large financial companies secretly circumvented government regulations designed to safeguard vulnerable investors from bad decision-making? Continue Reading

Do Firms Use Brands to Circumvent Regulatory Requirements?

Posted on March 21, 2019April 5, 2019 by Claire Hall

Have large financial companies secretly circumvented government regulations designed to safeguard vulnerable investors from bad decision-making?Continue Reading

XFL still working to clinch TV deal

Posted on March 14, 2019April 2, 2019 by Scott Slater III

The Hour – Eleven months from kickoff, the XFL has its teams, host cities and many of its coaches. It does not have a TV deal — at least not yet.

Waterbury Hosts Business and Human Rights Lecture Series

Posted on March 12, 2019 by Claire Hall, Courtney Akerley

An exterior view of the Waterbury Campus. (UConn photo)

Former Timex executive Bob Werner will be the keynote speaker during the second of a three-part lecture series on business and human rights, hosted at the UConn Waterbury campus. Continue Reading

Vineyard Vines to Launch Target Collection

Posted on March 11, 2019March 15, 2019 by Melissa Ferrigno

Stamford Advocate – Vineyard Vines, the preppy clothing company known for its smiling-whale logo, has launched one of its largest initiatives by teaming up with retailing giant Target.

Many sue OxyContin maker, but not its own city: Stamford

Posted on March 4, 2019April 2, 2019 by Scott Slater III

Westport News – Six of the state’s 10 largest cities, and hundreds of others across the country, have sued OxyContin maker Purdue Pharma. So has Connecticut’s attorney general and more than 30 of his counterparts.

Opioids: Boston trial opens what could be year of reckoning for executives

Posted on February 27, 2019March 1, 2019 by

The Guardian – Drug company executives appearing in court in Boston this week have been accused of running “a criminal enterprise” and putting greed before patient safety as they pushed prescription narcotics during the opioids crisis, blighting the health of America.

School of Business

About the School

Campuses

News & Events

Contact

Undergraduate Degree

Graduate Programs

MBA Programs

Specialized Masters

Professional Development

Overview

Academic Areas

Faculty & Ph.D.s

Research Centers

Recruit

Centers, Institutes, & Initiatives

Experiential Learning

Contact

Marketing

Student Profile: Grace Guertin ’19

Connecticut Turns Up Pressure on OxyContin Maker Purdue Pharma

British Drug Maker Indivior Indicted On Fraud And Conspiracy Charges In The U.S.

Do Firms Use Brands to Circumvent Regulatory Requirements?

Do Firms Use Brands to Circumvent Regulatory Requirements?

XFL still working to clinch TV deal

Waterbury Hosts Business and Human Rights Lecture Series

Vineyard Vines to Launch Target Collection

Many sue OxyContin maker, but not its own city: Stamford

Opioids: Boston trial opens what could be year of reckoning for executives

Upcoming Events